Friday 4 April 2003
Organizer R. Corrocher (Verona, Italy)

Hyperhomocysteinemia: pathophysiology and clinical implications

Session I
Chairs H. Blom (Nijmegen, The Netherlands) & R. Corrocher (Verona, Italy) Abstract No.
09.40 – 10.05 One-carbon metabolism and DNA methylation
S. Friso (Boston, USA / Verona, Italy)
10.05 – 10.30 MTHFR genotype, homocysteine, and risk of cardiovascular disease
D. Girelli (Verona, Italy)
10.30 – 10.55 Homocysteine as a risk of deep vein thrombosis
M. Cattaneo (Milano, Italy)
11.00 – 11.15 coffee break
11.15 – 11.40 Homocysteine and Alzheimer disease
G. Di Minno (Napoli, Italy)
11.40 – 12.05 B-vitamins, hyperhomocysteinemia and risk of neural tube defects
H. Blom (Nijmegen, The Netherlands)
12.05 – 1230 Discussion
12.30-12.40 Plasma homocysteine (tHcy) and kidney in diabetes mellitus
O. Giampietro, D. Calvi, G. Forotti, E. Boldrini, L. Moretti, and E. Matteucci (Pisa, Italy)
12.40 – 12.50 Determinants of total homocysteine plasma levels in type 2 diabetes
G.T. Russo, E. Alessi, A. Di Benedetto, G. Raimondo, and D. Cucinotta (Messina, Italy)
12.50 – 13.00 Prevalence of hyperhomocyst(e)inemia in patients with angiographically-assessed coronary artery disease and its associaton with peripheral vascular disease and chronic renal failure in the “GENICA” study
M. Cesari, M. Zanchetta, C. Ferrante, L. Pedon, P. Maiolino, A.C. Pessina, and G.P. Rossi (Padova, Italy)
13:00 End of workshop


Homocysteinemia and ischaemic risk
C. Belizna, M.A. Pistorius, and B. Planchon (Nantes, France)

Plasma homocysteine and vitamin B6 levels in relation to clinical evidence of atherosclerosis in type-2 diabetic patients
M. Cigolini, M. Galiotto, G. Faccini,V. Miconi, S. Lombardi, and R. Corrocher (Arzignano/Verona, Italy)